Unknown

Dataset Information

0

B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease.


ABSTRACT: Common variable immunodeficiency (CVID) is the most frequently diagnosed primary antibody deficiency. About half of CVID patients develop chronic non-infectious complications thought to be due to intrinsic immune dysregulation, including autoimmunity, gastrointestinal disease, and interstitial lung disease (ILD). Multiple studies have found ILD to be a significant cause of morbidity and mortality in CVID. Yet, the precise mechanisms underlying this complication in CVID are poorly understood. CVID ILD is marked by profound pulmonary infiltration of both T and B cells as well as granulomatous inflammation in many cases. B cell depletive therapy, whether done as a monotherapy or in combination with another immunosuppressive agent, has become a standard of therapy for CVID ILD. However, CVID is a heterogeneous disorder, as is its lung pathology, and the precise patients that would benefit from B cell depletive therapy, when it should administered, and how long it should be repeated all remain gaps in our knowledge. Moreover, some have ILD recurrence after B cell depletive therapy and the relative importance of B cell biology remains incompletely defined. Developmental and functional abnormalities of B cell compartments observed in CVID ILD and related conditions suggest that imbalance of B cell signaling networks may promote lung disease. Included within these potential mechanisms of disease is B cell activating factor (BAFF), a cytokine that is upregulated by the interferon gamma (IFN-?):STAT1 signaling axis to potently influence B cell activation and survival. B cell responses to BAFF are shaped by the divergent effects and expression patterns of its three receptors: BAFF receptor (BAFF-R), transmembrane activator and CAML interactor (TACI), and B cell maturation antigen (BCMA). Moreover, soluble forms of BAFF-R, TACI, and BCMA exist and may further influence the pathogenesis of ILD. Continued efforts to understand how dysregulated B cell biology promotes ILD development and progression will help close the gap in our understanding of how to best diagnose, define, and manage ILD in CVID.

SUBMITTER: Matson EM 

PROVIDER: S-EPMC7892472 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease.

Matson Erik M EM   Abyazi Miranda L ML   Bell Kayla A KA   Hayes Kevin M KM   Maglione Paul J PJ  

Frontiers in immunology 20210205


Common variable immunodeficiency (CVID) is the most frequently diagnosed primary antibody deficiency. About half of CVID patients develop chronic non-infectious complications thought to be due to intrinsic immune dysregulation, including autoimmunity, gastrointestinal disease, and interstitial lung disease (ILD). Multiple studies have found ILD to be a significant cause of morbidity and mortality in CVID. Yet, the precise mechanisms underlying this complication in CVID are poorly understood. CVI  ...[more]

Similar Datasets

| S-EPMC9255534 | biostudies-literature
| S-EPMC6483510 | biostudies-literature
| S-EPMC3557581 | biostudies-literature
| S-EPMC10568625 | biostudies-literature
| S-EPMC7987811 | biostudies-literature
| S-EPMC7874137 | biostudies-literature
| S-EPMC7858548 | biostudies-literature
| S-EPMC7059194 | biostudies-literature
| S-EPMC5140037 | biostudies-literature